Theranostics 2012; 2(2):125-126. doi:10.7150/thno.4129 This issue Cite

Editorial

Protease Activity: Meeting Its Theranostic Potential

Seulki Lee1✉, Kwangmeyung Kim2✉

1. Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, USA
2. Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Korea

Citation:
Lee S, Kim K. Protease Activity: Meeting Its Theranostic Potential. Theranostics 2012; 2(2):125-126. doi:10.7150/thno.4129. https://www.thno.org/v02p0125.htm
Other styles

File import instruction

Abstract

This themed issue provides up-to-date review and research articles covering the theranostic applications in the combined fields of protease research, diagnostics and drug development.

Keywords: Biomarkers, diagnosis, drug development, molecular imaging, proteases, theranostics


Citation styles

APA
Lee, S., Kim, K. (2012). Protease Activity: Meeting Its Theranostic Potential. Theranostics, 2(2), 125-126. https://doi.org/10.7150/thno.4129.

ACS
Lee, S.; Kim, K. Protease Activity: Meeting Its Theranostic Potential. Theranostics 2012, 2 (2), 125-126. DOI: 10.7150/thno.4129.

NLM
Lee S, Kim K. Protease Activity: Meeting Its Theranostic Potential. Theranostics 2012; 2(2):125-126. doi:10.7150/thno.4129. https://www.thno.org/v02p0125.htm

CSE
Lee S, Kim K. 2012. Protease Activity: Meeting Its Theranostic Potential. Theranostics. 2(2):125-126.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image